Quick Answer
Vanda Pharmaceuticals Inc. reported Total Assets of $488.95 million for fiscal year 2025.
Vanda Pharmaceuticals Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $488.95M | -25.5% |
| 2024 | $656.20M | +1.2% |
| 2023 | $648.44M | +2.2% |
| 2022 | $634.25M | +6.8% |
| 2021 | $593.79M | +11.3% |
| 2020 | $533.46M | +10.3% |
| 2019 | $483.75M | +45.7% |
| 2018 | $332.13M | +61.7% |
| 2017 | $205.43M | -2.4% |
| 2016 | $210.37M | -1.3% |
| 2015 | $213.05M | +24.1% |
| 2014 | $171.70M | +19.8% |
| 2013 | $143.35M | +5.8% |
| 2012 | $135.45M | -25.8% |
| 2011 | $182.62M | -14.3% |
| 2010 | $213.10M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $601.14M | -6.8% | -3.8% |
| June 30, 2025 | $624.75M | -4.1% | -1.1% |
| March 31, 2025 | $631.94M | -3.2% | -3.7% |
| December 31, 2024 | $656.20M | +1.2% | +1.7% |
| September 30, 2024 | $645.12M | +0.5% | -1.0% |
| June 30, 2024 | $651.37M | +1.5% | -0.2% |
| March 31, 2024 | $652.68M | +1.3% | +0.7% |
| December 31, 2023 | $648.44M | +2.2% | +1.1% |
- Vanda Pharmaceuticals Inc. showed a decrease of -25.5% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Vanda Pharmaceuticals Inc.’s total assets has grown by 129.4% (from $213.10 million to $488.95 million).
- The most recent figure is from Vanda Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: